| Product NDC: | 0024-5824 |
| Proprietary Name: | Jevtana |
| Non Proprietary Name: | cabazitaxel |
| Active Ingredient(s): | & nbsp; cabazitaxel |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-5824 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201023 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100617 |
| Package NDC: | 0024-5824-11 |
| Package Description: | 1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01) |
| NDC Code | 0024-5824-11 |
| Proprietary Name | Jevtana |
| Package Description | 1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01) |
| Product NDC | 0024-5824 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cabazitaxel |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20100617 |
| Marketing Category Name | NDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |